Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
125.91
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
125.91
Bid (Size)
124.99 (1)
Ask (Size)
135.00 (4)
Prev. Close
125.91
Today's Range
125.91 - 125.91
52wk Range
119.59 - 148.62
Shares Outstanding
122,180,759
Dividend Yield
2.26%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Balancing Dividends and Fundamentals: The Case of NYSE:DGX.
April 10, 2024
Uncovering Dividend Opportunities with QUEST DIAGNOSTICS INC (NYSE:DGX).
Via
Chartmill
Key Takeaways From Quest Diagnostics Analyst Ratings
March 20, 2024
Via
Benzinga
Performance
YTD
-10.59%
-10.59%
1 Month
-2.44%
-2.44%
3 Month
-6.20%
-6.20%
6 Month
+2.51%
+2.51%
1 Year
-12.29%
-12.29%
More News
Read More
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
March 19, 2024
Via
Chartmill
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
Via
MarketBeat
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
March 18, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
(DGX) - Analyzing Quest Diagnostics's Short Interest
March 05, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
February 27, 2024
Via
Chartmill
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
February 26, 2024
Via
Benzinga
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
February 07, 2024
Via
Benzinga
Is NYSE:DGX suited for dividend investing?
February 05, 2024
Via
Chartmill
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
February 02, 2024
Via
Benzinga
Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points
February 01, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 01, 2024
Via
Benzinga
Earnings Outlook For Quest Diagnostics
January 31, 2024
Via
Benzinga
Expert Ratings for Quest Diagnostics
December 07, 2023
Via
Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
Via
Benzinga
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
January 18, 2024
Via
InvestorPlace
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
Via
Benzinga
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
January 09, 2024
From
Ultima Genomics
Via
Business Wire
Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement
January 02, 2024
Via
Benzinga
Quest Diagnostics Gains Momentum: Analyst Highlights Strong Business Trends And Growth Opportunities
December 20, 2023
Via
Benzinga
Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement
December 13, 2023
Via
Benzinga
Exposures
Product Safety
Quest Diagnostics Inc. (NYSE: DGX) Highlighted for Surprising Price Action
December 12, 2023
Via
Investor Brand Network
Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight
December 04, 2023
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
November 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.